RxDoctor Payments Data

Kristie Truman, PA

Physician Assistant · Alma, MINPI 1003846080

Payments from drug & device makers

$2,163in general payments, 2019–2025

Across 168 payments — averaging $12.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$809
  • Genentech USA, Inc.$426
  • Eisai Inc.$225
  • Teva Pharmaceuticals USA, Inc.$130
  • AbbVie$111
  • Amgen$79
  • plus $383 from 14 others

What the payments were for

  • Food & beverage$2,10097%
  • Education$633%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,163 in reported general payments places this provider in the 85th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$30,179
Medicare patients
209
Services billed
339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BetaseronInterferon Beta-1b12$114,389
Glatiramer Acetate47$100,385
PlegridyPeginterferon Beta-1a12$96,846
NuplazidPimavanserin Tartrate14$81,409
Dimethyl Fumarate15$64,629
Teriflunomide21$38,891
Emgality PenGalcanezumab-Gnlm30$32,554
Ajovy AutoinjectorFremanezumab-Vfrm18$25,900
Carbidopa-LevodopaCarbidopa/Levodopa334$10,073
Levetiracetam177$9,466
Duloxetine Hcl229$8,715
Gabapentin437$8,047
Ropinirole Hcl304$7,143
Lacosamide53$6,345
Lamotrigine302$5,775

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
BiogenPlegridy$809$96,84612 claims
Acadia Pharmaceuticals IncNuplazid$33$81,40914 claims
Upsher-smith Laboratories LLCTopiramate$33$1,36879 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Alma

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →